Fig. 1: Comparison of FluTreo and FluTBI conditioning regimens.

a Non-relapse mortality. b Relapse incidence. c Leukemia-free survival. d Overall survival. e Survival free of grade III-IV acute graft-versus-host disease (GVHD) or severe chronic GVHD. All results are at 2 years except acute GVHD at 180 days post-hematopoietic stem cell transplantation.